|
Volumn 330, Issue 4, 2005, Pages 172-175
|
Stage IV thymic carcinoma: A study of 20 patients
|
Author keywords
Prognosis; Recurrence; Thymic carcinoma
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
GEMCITABINE;
PREDNISOLONE;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL FEATURE;
DISEASE ACTIVITY;
DISEASE COURSE;
DISEASE SEVERITY;
FEMALE;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LYMPHOEPITHELIOMA;
MALE;
PROGNOSIS;
SQUAMOUS CELL;
SURVIVAL TIME;
THYMUS CANCER;
WORLD HEALTH ORGANIZATION;
|
EID: 27244433477
PISSN: 00029629
EISSN: None
Source Type: Journal
DOI: 10.1097/00000441-200510000-00004 Document Type: Article |
Times cited : (19)
|
References (14)
|